Thymoma laboratory tests: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 9: | Line 9: | ||
[[Patient|Patients]] with thymoma can have the following [[Medical laboratory|laboratory]] findings:<ref name="pmid10561285">{{cite journal |author=Thomas CR, Wright CD, Loehrer PJ |title=Thymoma: state of the art |journal=[[Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology]] |volume=17 |issue=7 |pages=2280–9 |year=1999 |month=July |pmid=10561285 |doi= |url=http://www.jco.org/cgi/pmidlookup?view=long&pmid=10561285 |accessdate=2012-01-18}}</ref> | [[Patient|Patients]] with thymoma can have the following [[Medical laboratory|laboratory]] findings:<ref name="pmid10561285">{{cite journal |author=Thomas CR, Wright CD, Loehrer PJ |title=Thymoma: state of the art |journal=[[Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology]] |volume=17 |issue=7 |pages=2280–9 |year=1999 |month=July |pmid=10561285 |doi= |url=http://www.jco.org/cgi/pmidlookup?view=long&pmid=10561285 |accessdate=2012-01-18}}</ref> | ||
*[[Pure red cell aplasia]] on [[bone marrow biopsy]] | *[[Pure red cell aplasia]] on [[bone marrow biopsy]] | ||
*Hypogammaglobulinemia on [[protein electrophoresis]] | *Hypogammaglobulinemia on [[protein electrophoresis]]<ref>{{Cite journal | ||
| author = [[Y. Jamilloux]], [[H. Frih]], [[C. Bernard]], [[C. Broussolle]], [[P. Petiot]], [[N. Girard]] & [[P. Seve]] | |||
| title = [Thymoma and autoimmune diseases] | |||
| journal = [[La Revue de medecine interne]] | |||
| volume = 39 | |||
| issue = 1 | |||
| pages = 17–26 | |||
| year = 2018 | |||
| month = January | |||
| doi = 10.1016/j.revmed.2017.03.003 | |||
| pmid = 28365191 | |||
}}</ref> | |||
*[[Antibodies]] to the [[acetylcholine receptor]] (indicative of [[myasthenia gravis]]) | *[[Antibodies]] to the [[acetylcholine receptor]] (indicative of [[myasthenia gravis]]) | ||
*[[Liver enzyme]]s | *[[Liver enzyme]]s | ||
*[[Renal function]] | *[[Renal function]] | ||
*[[ANA|Antineutrophil antibody]] | *[[ANA|Antineutrophil antibody]] | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Revision as of 14:06, 15 August 2019
|
Thymoma Microchapters |
|
Diagnosis |
|---|
|
Case Studies |
|
Thymoma laboratory tests On the Web |
|
American Roentgen Ray Society Images of Thymoma laboratory tests |
|
Risk calculators and risk factors for Thymoma laboratory tests |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Amr Marawan, M.D. [2] Ahmad Al Maradni, M.D. [3]
Overview
Laboratory findings associated with thymoma may include antibodies against the acetylcholine receptor, abnormal electrolytes, renal, and liver function tests.
Laboratory Findings
Patients with thymoma can have the following laboratory findings:[1]
- Pure red cell aplasia on bone marrow biopsy
- Hypogammaglobulinemia on protein electrophoresis[2]
- Antibodies to the acetylcholine receptor (indicative of myasthenia gravis)
- Liver enzymes
- Renal function
- Antineutrophil antibody
References
- ↑ Thomas CR, Wright CD, Loehrer PJ (1999). "Thymoma: state of the art". Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 17 (7): 2280–9. PMID 10561285. Retrieved 2012-01-18. Unknown parameter
|month=ignored (help) - ↑ Y. Jamilloux, H. Frih, C. Bernard, C. Broussolle, P. Petiot, N. Girard & P. Seve (2018). "[Thymoma and autoimmune diseases]". La Revue de medecine interne. 39 (1): 17–26. doi:10.1016/j.revmed.2017.03.003. PMID 28365191. Unknown parameter
|month=ignored (help)